Abstract: Shot-peening powder that has ceramic particles. The powder having more than 95% by mass of beads. The beads having a median size D50 greater than 50 ?m and less than 1200 ?m, and having a value (D90?D10)/D50, or “S”, such that S??0.126·ln(D50)+0.980.

Abstract: The present Disclosure is directed to methods for inhibiting or suppressing metastasis of a tumor in a mammalian subject using a cysteamine product, e.g., cysteamine or cystamine or a derivative thereof. Also described herein is a method for treating pancreatic cancer in a mammalian subject by administering a cysteamine product described herein.

Abstract: Hybrid multirotor vehicles and related methods are disclosed herein. An example aircraft includes a battery, a rotor coupled to a wing, a motor operatively coupled to the rotor, and a processor operatively coupled to the motor. The processor to is cause the motor to operate in a first motor operational state. The rotor is to operate in a first rotor operational state when the motor is operating in the first motor operational state. The processor is to cause the motor to switch from operating in the first motor operational state to a second motor operational state. The rotor is to operate in a second rotor operational state when the motor is in the second motor operational state. The motor is to provide electrical energy to the battery in the second motor operational state and the rotor is to autorotate in the second rotor operational state.

Abstract: Shot-peening method. Projecting a powder onto a surface. The powder includes sintered particles, more than 95 wt % of the particles are beads. The powder has, in wt % based on the oxides: —ZrO2 partially stabilized with CeO2 and Y2O3: balance to 100%, CeO2 and Y2O3 present, in mol % according to the sum of ZrO2, CeO2 and Y2O3, CeO2: 2.5-11 mol % and Y2O3: 0.5-2 mol %, —Al2O3; 3-50%—additive chosen from CaO, manganese oxides, ZnO, praseodymium oxides, SrO, copper oxides, 0.2-6% Nd2O3, BaO, iron oxides, and mixtures thereof: CaO being less than 2%, —elements other than ZrO2, CeO2, Y2O3, Al2O3, CaO, manganese oxides, ZnO, praseodymium oxides, ?5% SrO, copper oxides, Nd2O3, BaO, and iron oxides: manganese oxides, praseodymium oxides, copper oxides and iron oxides being expressed as MnO, Pr6O11, CuO and Fe2O3, respectively, and a relative density greater than 95%.

Abstract: Shot-peening powder that has ceramic particles. The powder having more than 95% by mass of beads. The beads having a median size D50 greater than 50 ?m and less than 1200 ?m, and having a value (D90?D10)/D50, or “S”, such that S??0.126·ln(D50)+0.980.

Abstract: Provided herein are methods of generating a population of enucleated erythroid cells.

Abstract: Provided herein are methods of generating a population of enucleated erythroid cells.

Abstract: Hybrid multirotor vehicles and related methods are disclosed herein. An example aircraft includes a battery, a rotor coupled to a wing, a motor operatively coupled to the rotor, and a processor operatively coupled to the motor. The processor to is cause the motor to operate in a first motor operational state. The rotor is to operate in a first rotor operational state when the motor is operating in the first motor operational state. The processor is to cause the motor to switch from operating in the first motor operational state to a second motor operational state. The rotor is to operate in a second rotor operational state when the motor is in the second motor operational state. The motor is to provide electrical energy to the battery in the second motor operational state and the rotor is to autorotate in the second rotor operational state.

Abstract: One aspect of the invention relates to a genetically modified thermophilic or mesophilic microorganism, wherein a first native gene is partially, substantially, or completely deleted, silenced, inactivated, or down-regulated, which first native gene encodes a first native enzyme involved in the metabolic production of an organic acid or a salt thereof, thereby increasing the native ability of said thermophilic or mesophilic microorganism to produce lactate or acetate as a fermentation product. In certain embodiments, the aforementioned microorganism further comprises a first non-native gene, which first non-native gene encodes a first non-native enzyme involved in the metabolic production of lactate or acetate. Another aspect of the invention relates to a process for converting lignocellulosic biomass to lactate or acetate, comprising contacting lignocellulosic biomass with a genetically modified thermophilic or mesophilic microorganism.

Abstract: One aspect of the invention relates to a genetically modified thermophilic or mesophilic microorganism, wherein a first native gene is partially, substantially, or completely deleted, silenced, inactivated, or down-regulated, which first native gene encodes a first native enzyme involved in the metabolic production of an organic acid or a salt thereof, thereby increasing the native ability of said thermophilic or mesophilic microorganism to produce lactate or acetate as a fermentation product. In certain embodiments, the aforementioned microorganism further comprises a first non-native gene, which first non-native gene encodes a first non-native enzyme involved in the metabolic production of lactate or acetate. Another aspect of the invention relates to a process for converting lignocellulosic biomass to lactate or acetate, comprising contacting lignocellulosic biomass with a genetically modified thermophilic or mesophilic microorganism.

Abstract: Described is a method of using gadolinium-containing compounds as agents for neutron capture therapy to treat neoplastic cell growth. The subject is exposed to a gadolinium-containing compound for a time sufficient to allow the compound to accumulate in neoplastic cells. The subject is then exposed to a thermal and/or epithermal neutron flux, thereby initiating a neutron capture reaction in the gadolinium atoms that results in specific death of neoplastic cells.

Abstract: Described is a method of using gadolinium-containing compounds as agents for neutron capture therapy to treat neoplastic cell growth. The subject is exposed to a gadolinium-containing compound for a time sufficient to allow the compound to accumulate in neoplastic cells. The subject is then exposed to a thermal and/or epithermal neutron flux, thereby initiating a neutron capture reaction in the gadolinium atoms that results in specific death of neoplastic cells.

Abstract: A process for separating water from methanol in an aqueous methanol initial mixture, comprising subjecting said mixture to azeotropic distillation in the presence of sufficient added methyl acrylate to form an azeotrope with most of the methanol in said initial mixture such that a substantial proportion of methanol in the initial mixture is removed as an azeotrope of methanol and methyl acrylate in the overhead vapors resulting from said distillation and a major proportion of water in said initial mixture is removed in the liquid residue of said distillation.

Abstract: A process for separating water from methanol in an aqueous methanol initial mixture, including subjecting said mixture to azeotropic distillation in the presence of sufficient added methyl acrylate to form an azeotrope with most of the methanol in said initial mixture such that a substantial proportion of methanol in the initial mixture is removed as an azeotrope of methanol and methyl acrylate in the overhead vapors resulting from said distillation and a major proportion of water in said initial mixture is removed in the liquid residue of said distillation.

Abstract: A process for separating water from methanol in an aqueous methanol initial mixture, comprising subjecting said mixture to azeotropic distillation in the presence of sufficient added methyl acrylate to form an azeotrope with most of the methanol in said initial mixture such that a substantial proportion of methanol in the initial mixture is removed as an azeotrope of methanol and methyl acrylate in the overhead vapors resulting from said distillation and a major proportion of water in said initial mixture is removed in the liquid residue of said distillation.